Tuesday, January 16, 2018
As an investor in ChromaDex (CDXC), and a user of their lead product Tru Niagen, I'm a firm believer in the health benefits of Nicotinamide Riboside (NR). NR in its consumer form is more commonly known as Niagen, which is...
IRVINE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today the financial results for the quarter ended September 30, 2017. Frank Jaksch, Jr., CEO and co-founder of ChromaDex commented, “The science continues to...
Tailwinds' Take: a great new hire for the Company, Farr has the experience to help build Tru Niagen into a global consumer brand. His leaving a large global business like Mattel to join CDXC demonstrates the upside potential here. IRVINE,...
Tailwinds' Take: very positive news for CDXC as this demonstrates the positive effects of Niagen in anti-aging activity. Expect more studies to continue showing efficacy and Niagen to become the next blockbuster supplement in the market. IRVINE, Calif., Sept. 26,...
Tailwinds' Take: Watsons is a great partner. The Asian market is the largest for sales of supplements and Tru Niagen is poised to be a very big commercial success overseas. This is the first step towards massive growth for...
This morning we have added Chromadex to the Tailwinds Select Portfolio at a price of $3.91. Chromadex holds the worldwide rights to Niagen, a member of the vitamin B-3 family that helps promote healthier living and longer lives. CDXC...
IRVINE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that in research published in the journal Nature, Dr. Johan Auwerx showed that Alzheimer’s disease...
Tailwinds' Take: the implications of this study are potentially massive. It truly appears that NR has many positive effects and is well on its way to becoming a blockbuster supplement. No side effects, many benefits. There appears to be...
Tailwinds' Take: based on their "successful", to quote the Company, launch in Hong Kong, this is probably the first of several more markets that Watsons will open up to Tru Niagen. CDXC remains on track to have a blockbuster...
Company Reports Revenue of $5.3 Million for Q2 2017-  Continued Progress on Building a Consumer Products Platform Around TruNiagen®- IRVINE, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (CDXC), an innovator of proprietary health, wellness and nutritional ingredients,...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address